Skip to main content
Clinical Trials/NCT01146717
NCT01146717
Completed
Not Applicable

Mild Cognitive Impairment:Cerebrovascular Dysfunction and Exercise

University of Texas Southwestern Medical Center1 site in 1 country80 target enrollmentMarch 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
University of Texas Southwestern Medical Center
Enrollment
80
Locations
1
Primary Endpoint
Cognitive function
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study is being done to find out whether regulation of brain blood flow is altered in patents with mild cognitive impairment (those who have memory problems but otherwise healthy) when compared with healthy elderly individuals. In addition, this study will determine whether exercise training improves brain blood flow, brain structure, and brain function in patients with mild cognitive impairment (MCI).

This is a research study because at present the investigators know little about brain blood flow regulation in patients with mild cognitive impairment. The investigators also know little about whether exercise training improves brain blood flow, brain structure, and brain function in patients with mild cognitive impairment.

Detailed Description

We plan to study 70 patients with amnestic MCI and 30 healthy older adults with similar age, sex, and educational level in this research at the University of Texas Southwestern(UTSW) Medical Center Dallas and Texas Health Presbyterian Hospital Dallas - Institute for Exercise an Environmental Medicine (IEEM). To help decide if you qualify to be in this study, the researchers may ask you questions about your health, including medications you take and any surgical procedures you have had. You may also have to fill out certain forms or have the following exams, tests or procedures. The screening process usually takes 2-3 hours. You will be required to come for 7-9 visits including the initial screening for eligibility to participate in this study. The experiments will measure your brain perfusion, vascular function and exercise capacity. For the healthy controls, the expected length of this study will be about 2-3 months including all the test visits. Your participation in this study will end following completion of your testing. For those with Mild Cognitive Impairment, the expected length of this study will be about 18 months including all the test visits and exercise training. Your participation in this study will end following completion of your repeat testing after one-year exercise training or control intervention. On occasion, training may be delayed due to injury, illness or personal matters. If this is the case, your enrollment in the study may last longer than one year as we attempt to complete the training and testing.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
September 2016
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rong Zhang

Dr. Rong Zhang, UTSW

University of Texas Southwestern Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age 55-80 years old, Male or Female
  • Control Subjects: absence of cognitive complaints and normal performance in Uniform Data Set (UDS) neuropsychological tests.
  • For patients: Diagnosis of amnestic MCI (single and multiple domains) by Petersen's criteria (as modified for ADNI-GO study).
  • Stable medical condition for \> 6 months
  • Sable medications for \>2 months (use of cholinesterase inhibitors, or prior use of multivitamins is allowed)
  • Caregiver/informant available to accompany patient for scheduled visits in case the patient develops cognitive impairment that interferes with independent study participation.
  • Fluency of patient and caregiver in English
  • Ability to return to clinic for additional visits over a 12 month period.
  • ≥ 10 years of education or enough work history to exclude mental retardation.
  • Adequate visual and auditory acuity to allow neuropsychological testing.

Exclusion Criteria

  • Diagnosis of Alzheimer's Disease or other type of dementia.
  • Participant enrolled in any other investigational drug study within 2 months or longer, depending on the investigational drug half-life.
  • Modified Hachinski Score ≥
  • Subject has history in the past 2 years of epileptic seizures, or DSM-IV criteria of any major psychiatric disorders.
  • Past history or MRI evidence of brain damage including significant trauma, stroke, hydrocephalus, mental retardation or serious neurological disorder.
  • Carotid stent or sever stenosis.
  • Significant history of active alcoholism or drug abuse.
  • History of myocardial infarction within the previous year. Unstable cardiac, renal, lung, liver or other severe chronic diseases.
  • Uncontrolled hypertension (Systolic Blood Pressure (SBP) ≥160, Diastolic Blood Pressure (DBP) ≥100)or hypotension (SBP \<100 mmHg).
  • Currently diagnosed and being treated for Diabetes Mellitus (DM).

Outcomes

Primary Outcomes

Cognitive function

Time Frame: One year

A comprehensive battery of neuropsychological tests focused on memory and executive function will be used to assess effects of exercise on cognitive function.

Secondary Outcomes

  • Cerebrovascular function(One year)
  • Brain tissue volume and white matter integrity(One year)

Study Sites (1)

Loading locations...

Similar Trials